FDA revokes emergency authorization for chloroquine and hydroxychloroquine in COVID-19 treatment

FDA revokes emergency authorization for chloroquine and hydroxychloroquine in COVID-19 treatment

TechCrunch·2020-06-16 05:55

Play this highly-restored Pokemon classic now! Gotta catch 'em all!
Earn 50 points by checking in daily during the Circuit Breaker period!

The U.S. Food and Drug Administration (FDA) has revoked an emergency use authorization (EUA) that it previously issued for chloroquine and hydroxychloroquine, two anti-malarial drugs also used in the treatment of chronic rheumatoid arthritis (via The Washington Post). These are the drugs that President Trump famously touted as effective in COVID-19 treatment, despite major concerns raised with the scientific validity of early medical investigations that showed they were potentially effective against the infection beyond the ongoing global pandemic.

……

Read full article on TechCrunch

America Health Technology International

Comments

Leave a comment in Nestia App